Andrea S. James bought $100k of IMDX
Chief Financial Officer at Oncocyte Corp. 33,670 shares at an average of $2.97, traded Oct 2, 2024, filed Oct 4, 2024.
Score components
- +22RoleCFO
- +10Trade size$100k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +4Price context28% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +3.8%, 3m -18.0%, 6m -4.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-039603, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 2, 2024 | POpen-market purchase Common Stock, no par value | +33,670 | $2.97 | $100k | 33,670 | Oct 4, 2024 |
Related signals
Other insiders at Oncocyte Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IMDXbuy Oncocyte Corp | Broadwood Partners, L.p. owner | $2.0M 570,184 shares | +5% | |
| 40Moderate | IMDXbuy Oncocyte Corp | Broadwood Partners, L.p. owner | $653k 182,861 shares | +2% | |
| 32Weak | IMDXbuy Oncocyte Corp | Broadwood Partners, L.p. owner | $3.0M 521,739 shares | +5% | |
| 57Moderate | Oncocyte Corp | Andrea S. James Chief Financial Officer | $200k 97,561 shares | +182% | |
| 50Moderate | Oncocyte Corp | Broadwood Partners, L.p. owner | $11M 5,165,695 shares | +83% | |
| 30Weak | Oncocyte Corp | Patrick W Smith owner | $192k 90,219 shares | +5% | |
| 31Weak | Oncocyte Corp | Andrew Arno director | $26k 12,500 shares | +18% | |
| 38Weak | IMDXbuy Oncocyte Corp | Andrea S. James Chief Financial Officer | $46k 20,000 shares | +59% | |
| 60Notable | Oncocyte Corp | Broadwood Partners, L.p. owner | $3.9M 1,315,339 shares | +27% | |
| 58Moderate | Oncocyte Corp | Andrew Arno director | $100k 33,898 shares | +96% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.